SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-04-001843
Filing Date
2004-05-07
Accepted
2004-05-07 12:01:49
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q w97154e10vq.htm 10-Q 148366
2 EXHIBIT 31.1 w97154exv31w1.htm EX-31.1 7301
3 EXHIBIT 31.2 w97154exv31w2.htm EX-31.2 7315
4 EXHIBIT 32.1 w97154exv32w1.htm EX-32.1 3465
5 EXHIBIT 32.2 w97154exv32w2.htm EX-32.2 3740
  Complete submission text file 0000950133-04-001843.txt   172183
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 04787686
SIC: 2836 Biological Products, (No Diagnostic Substances)